Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scoring in patients with breast cancer.

Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Dr Mariana Chavez MacGregor reports on advances from ASCO 2025, emphasizing treatment de-escalation and emerging tools like ctDNA for personalized care.

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...